Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 9.3.2020Zentiva, k.s. (ZNT-1)81830Valzap HCT 160 mg/12,5 mg (tbl flm 28x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al))5.3.2020O
 9.3.2020Zentiva a.s. (ZNT-SK-2)70425Rhefluin (tbl 30x5,68 mg/50 mg (blis. Al/PVC))11.3.2020O
 9.3.2020medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)40197BCG-medac (plv suf 1x1 set (1xliek.inj.skl.+1x50 ml vehikulum+adapt.Luer-Lock))9.3.2020O
 6.3.2020Bayer, spol. s r.o. (BAY-SK-2)33060Aspirin 500 mg (tbl 10x500 mg (blis.PP/Al))9.3.2020R
 6.3.2020G.L. Pharma GmbH (GLH-2)2810CMetamilan 500 mg tablety (tbl 20x500 mg (blis.PVC/Al))24.2.2020O
 6.3.2020G.L. Pharma GmbH (GLH-2)66157Paroxetin G.L. Pharma 20 mg (tbl flm 30x20 mg (blis.Al/Al))31.10.2019O
 6.3.2020G.L. Pharma GmbH (GLH-2)89839Oxypro 40 mg tablety s predĺženým uvoľňovaním (tbl plg 60x40 mg (blis.PVC/PVDC/Al))6.3.2020R
 6.3.2020Instituto Grifols, S.A. (GFO)45082Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x100 ml/5 g (liek.skl.))6.3.2020R
 6.3.2020MERCK spol. s r.o. (MRS)1362CConcor COR 5 mg (tbl flm 100x5 mg (blis.PVC/Al))6.3.2020R
 6.3.2020MERCK spol. s r.o. (MRS)97761Bisomerck 5 (tbl flm 30x5 mg)6.3.2020R
 6.3.2020MERCK spol. s r.o. (MRS)34862Lodoz 2,5 mg/6,25 mg (tbl flm 30 (blis.PP/Al))6.3.2020O
 6.3.2020Glenmark Pharmaceuticals s.r.o. (GLM-CZ)0446BMEDIPYRIN 500 (tbl 30x500 mg (blis.PVC/Al))15.3.2020R
 6.3.2020Egis Pharmaceuticals PLC (EGI)00560Plegomazin 0,5% (sol inj 10x5 ml/25 mg (amp. skl.))15.3.2020R
 5.3.2020CSL Behring GmbH (CSL)07753Hizentra 200 mg/ml roztok na subkutánnu injekciu (sol icu 1x10 ml/2 g (liek.inj.skl.))5.3.2020O
 5.3.2020B.Braun Melsungen AG (BME)96890Aminoplasmal Hepa 10% (sol inf 1x500 ml (fľ.skl.))5.3.2020O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)